Press Releases
 2009
PRESS RELEASE | 18 NOVEMBER 2009
The European Generic medicines Association (EGA) welcomes Didier Barret as its new President, unanimously elected by the EGA Board of Directors today in Brussels. More...
PRESS RELEASE | 10 NOVEMBER 2009
STOP FAKE MEDICINES: FOCUS ON SUPPLY CHAIN INTEGRITY AND CRIMINALISATION SAY MEPS AND EXPERTS
Policy makers must shift the focus away from technological measures to stop counterfeiting of medicines and look at real and effective solutions such as implementing and increasing criminal sanctions while ensuring that all parties do business only with certified and reliable partners. More...
PRESS RELEASE | 2 OCTOBER 2009
THE EU PHARMACEUTICAL SECTOR INQUIRY RECOMMENDATIONS - NOT TENDERING SYSTEMS - PROVIDE THE KEY TO INCREASING PATIENT ACCESS TO AFFORDABLE GENERIC MEDICINES
Tendering is undermining the long-term patient access to generic medicines” and “it is urgent that governments start to see that pricing and reimbursement measures must be about more than just short term price decreases”, said Eric Gorka EGA President More...
PRESS RELEASE | 30 SEPTEMBER 2009
BEHAVIOURAL MEASURES ARE KEY IN PROTECTING PATIENTS AGAINST COUNTERFEITED MEDICINES IN EUROPE
The European Generic medicines Association (EGA) believes that the fight against counterfeiting should primarily focus on behavioural measures that ensure patients’ and supply chain security, by harmonising criminal law among member states. More...
PRESS RELEASE | 25 September 2009
QUICK IMPLEMENTATION OF SECTOR INQUIRY RECOMMENDATIONS IS THE ROADMAP FOR BUILDING SUSTAINABLE HEALTHCARE SYSTEMS IN SOUTH EAST EUROPE
"National agencies from the South East European region should intensify cooperation and harmonisation and look at strengthening their regulatory framework. Quick alignment with the recommendations of the European Commission’s pharmaceutical sector inquiry report is the roadmap for building a sustainable pharmaceutical sector throughout Europe” says EGA director general, Greg Perry opening the 5th EGA South East Europe Pharmaceutical Symposium in Ohird, Macedonia. More...
PRESS RELEASE | 8 July 2009
EUROPEAN COMMISSION INQUIRY RECOMMENDS SYSTEMIC IMPROVEMENTS TO ENSURE IMMEDIATE ACCESS FOR PATIENTS TO AFFORDABLE GENERIC MEDICINES UPON PATENT EXPIRY
The EGA welcomes the European Commission’s Final Report on the Pharmaceutical Sector Inquiry and calls on European and national authorities for quick implementation of the conclusions and recommendations. More...
PRESS RELEASE | 4 June 2009
REPORT PROPOSES MEASURES TO INCREASE PATIENT ACCESS TO GENERIC MEDICINES
“EU governments need to ensure fast generic medicines uptake, as market access and low market volume in key EU countries is still a real problem and is having a major negative impact on patient access to more affordable treatments”. This is the key message Greg Perry, director general of the EGA, made at the European Generic medicines Association’s 15th EGA Annual Conference at Barcelona during the launch of a new EGA report...
PRESS RELEASE | 23 April 2009
TOWARDS GLOBAL DEVELOPMENT AND MONOCLONAL ANTIBODIES | TAKING BIOSIMILAR MEDICINES TO THE NEXT LEVEL
EGA Director General Greg Perry today congratulated industry and medicines regulators on the EU’s ‘biosimilar thinking’. “The EU continues to lead worldwide in developing new guidelines and is now taking biosimilar medicines to the next level", he said.
PRESS RELEASE | 8 April 2009
EGA SEEKS BALANCE BETWEEN PATENTS AND THE PUBLIC INTEREST IN PROPOSED EU “UNIFIED PATENT LITIGATION SYSTEM”
The EGA welcomes the European Commission’s initiative for a Unified Patent Litigation System, while recommending safeguards to ensure a fairer balance between patent holders and the public interest.
PRESS RELEASE | 1 April 2009
PRESSURES ON GENERIC MEDICINES PUT EU HEALTHCARE AT RISK
Greg Perry, director general of
EGA, warns that "the future of the European generic medicines industry is
under serious threat, which places both the sustainability of European healthcare
and European industrial competitiveness at serious risk.”
PRESS RELEASE | 24 March 2009
EGA STRESSES NEED FOR URGENT IMPROVEMENTS
TO REGULATORY SYSTEM FOR MEDICINES APPROVAL
Participating at the DIA Conference in Berlin, the EGA again stressed the urgent need to optimise the regulatory system for approving generic medicines and other medicinal products which contain known active substances.
PRESS RELEASE | 17 March 2009
BETTER PATENTS MAKE BETTER MEDICINES |
AT THE EUROPEAN PARLIAMENT THE EGA EMPHASISES THE NEED TO IMPROVE EFFICIENCY IN THE EUROPEAN PATENT SYSTEM
Greg Perry, director general of
the EGA, speaking at a STOA meeting in the European Parliament, welcomed STOA’s initiative to enhance patent awareness and renewed the EGA’s commitment to constructive dialogue with the European Parliament and the EPO improve the efficiency of Europe’s patent system.
PRESS RELEASE | 13 March 2009
BETTER PATENTS MAKE BETTER MEDICINES |
IMPROVED EFFICIENCY OF THE EUROPEAN PATENT SYSTEM WOULD STIMULATE INNOVATION AND COMPETITION
IN THE PHARMACEUTICAL SECTOR
Greg Perry, director general of the EGA, opened the 5th EGA Legal Affairs Forum by highlighting the generic medicines industry’s role in European healthcare, and warning of increasing hurdles to competition and real innovation if the European patent system is not reformed.
PRESS RELEASE | 29 January 2009
EUROPE’S STRONGLY COMPETITIVE GENERIC MEDICINES INDUSTRY WARNS OF INCREASING BURDENS AND HURDLES
Greg Perry, director general of
the EGA, opened the 8th EGA Scientific and Regulatory
Affairs Conference by highlighting his industry’s
role in European healthcare, and warning of increasing cost burdens
and hurdles to competition.
PRESS RELEASE | 28 January 2009
MEB—EGA INFO DAY: ONGOING JOINT COOPERATION TO MEET GROWING EXPECTATIONS
The Medicines Evaluation Board of the Netherlands (MEB) and the EGA held the first MEB-EGA Information Day, the second in a series of meetings with European medicines authorities aimed at strengthening communications.
|
